PharmGen Science: Largest Shareholder Stake Rises from 19.88% to 20.31% (CB Conversion etc.)
-
Largest shareholder group stake increased from 19.88% to 20.31% (+0.43pp), shares held from 4,363,238 to 4,602,438 (+239,200 shares)
-
Increase due to conversion of CB by Han Dae-hee (relative), acquiring 269,179 shares
-
Decrease due to retirement of executive Kim Hye-yeon, reducing 29,979 shares (Mar 31)
KOSPI Filing Information
-
Filing: Report on Change in Ownership of Major Shareholders, etc.
-
Company: PharmGen Science (004720)
-
Submission: PharmGen Science, Inc.
-
Receipt: 05-12-2026
-
Under KRX KOSPI Market Division